Peer Reviewed Open Access Journal
Volume 2 - Issue 2, March - April 2026
📑 Paper Information
| 📑 Paper Title | A Study on Financial Performance of Indian Pharmaceutical Industry |
| 👤 Authors | Dr.P.Kanagaraj, Mr.Sri Gokul.R |
| 📘 Published Issue | Volume 2 Issue 2 |
| 📅 Year of Publication | 2026 |
| 🆔 Unique Identification Number | IJAMRED-V2I2P55 |
| 📑 Search on Google | Click Here |
📝 Abstract
The Indian pharmaceutical industry plays a crucial role in global healthcare by supplying affordable generic medicines, vaccines, and active pharmaceutical ingredients (APIs). Being a research-intensive and regulation-driven sector, maintaining strong financial performance is essential for sustainability and global competitiveness. This study examines the liquidity and solvency position of five leading Indian pharmaceutical companies—Sun Pharmaceutical Industries Ltd, Dr.Reddy’s Laboratories Ltd, Cipla Ltd, Divi’s Laboratories Ltd, and Lupin Ltd—over a five-year period from FY2021 to FY2025.
📝 How to Cite
Dr.P.Kanagaraj, Mr.Sri Gokul.R, "A Study on Financial Performance of Indian Pharmaceutical Industry" International Journal of Advanced Multidisciplinary Research and Educational Development, V2(2): Page(350-353) Mar-Apr 2026. ISSN: 3107-6513. www.ijamred.com. Published by Scientific and Academic Research Publishing.
Email Address
- editorijamred@gmail.com
Our Policy
Copyright © . Scientific and Academic Research Publishing, All Rights Reserved.
